Search results
Processa reports positive Phase 1b trial results for cancer drug By Investing.com
Investing.com· 4 days agoProcessa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company, has announced...
NodThera's NLRP3 inhibitor shows further anti-inflammatory promise in phase 1b/2a obesity trial
FierceBiotech· 3 days agoNow, an early readout from a study in humans with obesity has again demonstrated the drug’s anti-inflammatory potential. The phase 1b/2a trial saw patients ...
2024 MLB Draft player rankings: College bats lead list of top 30 prospects in class
CBS Sports· 13 hours agoMajor League Baseball's amateur draft is now exactly a month away. The Cleveland Guardians will be...
Surrozen reports positive Phase 1a trial results for liver therapy By Investing.com
Investing.com· 5 days agoThe study, which involved healthy volunteers and patients with a history of liver cirrhosis, was...
DeSantis slashes $68.8 million from state budget in projects for Miami-Dade and Broward
Miami Herald via Yahoo News· 2 days agoLocal programs in Miami-Dade and Broward focused on youth crime prevention, pedestrian safety and...
Pfizer faces setback with gene therapy acquired from North Carolina firm - Triangle Business Journal
The Business Journals· 2 days agoPfizer is facing a major clinical setback in a gene therapy program with ties to the Triangle. The...
Are Dollarama Inc. (TSE:DOL) Investors Paying Above The Intrinsic Value?
Simply Wall St. via Yahoo Finance· 20 hours ago1b The second stage is also known as Terminal Value, this is the business's cash flow after the...
DARPA unveils 6 new designs for uncrewed vertical-takeoff military aircraft, eyes 2026 test flights
Space via Yahoo News· 4 days agoANCILLARY is currently in phase 1b, with testing set to run for 10 months from June 2024 to spring...
Fort Worth Stockyards: $1B expansion would nearly double the entertainment district
Fort Worth Star-Telegram via Yahoo Finance· 3 days agoThe city’s economic development manager, Michael Hennig, presented the proposal to the City Council...
Mereo BioPharma Group (NASDAQ:MREO) Shares Up 4.7% After Analyst Upgrade
ETF DAILY NEWS· 1 day agoMereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was up 4.7% during trading on Thursday after Needham & Company LLC raised their price target on the stock from $6.00 to $7.00. Needham ...